share_log

HC Wainwright & Co. Initiates Coverage On PaxMedica With Buy Rating, Announces Price Target of $3

Benzinga ·  Dec 4, 2023 06:45

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on PaxMedica (NASDAQ:PXMD) with a Buy rating and announces Price Target of $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment